We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
-$54.5M
Cap. Flow
+$154M
Cap. Flow %
10.62%
Top 10 Hldgs %
43.38%
Holding
129
New
42
Increased
32
Reduced
24
Closed
24
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$37.6M
2
CYH icon
Community Health Systems
CYH
+$28.3M
3
ASND icon
Ascendis Pharma A/S
ASND
+$27.8M
4
CTLT icon
CATALENT, INC.
CTLT
+$23M
5
MASI icon
Masimo
MASI
+$18.2M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$26.7M
2
AMRN icon
Amarin Corp
AMRN
+$24.9M
3
OGN icon
Organon & Co
OGN
+$21.2M
4
DHR icon
Danaher
DHR
+$17.4M
5
AMN icon
AMN Healthcare
AMN
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 80.74%
2 Miscellaneous 17.65%
3 Industrials 1.16%
4 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NVAX icon
76
CALL
Novavax
NVAX
$1.86B
$2.07M 0.14%
10,000
– –
2021 Q1
2 quarters
EDIT icon
77
PUT
Editas Medicine
EDIT
$361M
$2.05M 0.14%
+50,000
New +$2.74M
2021 Q3
0 quarters
TECX icon
78
Tectonic Therapeutic
TECX
$404M
$2.01M 0.14%
+29,957
New +$2.46M
2021 Q3
0 quarters
GOSS icon
79
Gossamer Bio
GOSS
$53.6M
$1.88M 0.13%
+1,874
New +$1.38M
2021 Q3
0 quarters
MYO icon
80
Myomo
MYO
$47.5M
$1.78M 0.12%
+150,000
New +$1.49M
2021 Q3
0 quarters
ARGX icon
81
argenx
ARGX
$51.5B
$1.74M 0.12%
+5,746
New +$1.82M
2021 Q3
0 quarters
MRTX
82
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.65M 0.11%
+9,355
New +$1.51M
2021 Q3
0 quarters
IQV icon
83
IQVIA
IQV
$43.9B
$1.63M 0.11%
6,790
+1,078
+19% +$272K
2020 Q4
3 quarters
LOGC
84
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.6M 0.11%
+349,919
New +$1.54M
2021 Q3
0 quarters
ACIU icon
85
AC Immune
ACIU
$238M
$1.49M 0.1%
+221,749
New +$1.59M
2021 Q3
0 quarters
DNTH icon
86
Dianthus Therapeutics
DNTH
$4.03B
$1.45M 0.1%
+12,430
New +$1.45M
2021 Q3
0 quarters
ACAD icon
87
CALL
Acadia Pharmaceuticals
ACAD
$3.29B
$1.41M 0.1%
84,600
– –
2021 Q1
2 quarters
ORTX
88
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.31M 0.09%
+56,958
New +$1.69M
2021 Q3
0 quarters
AKYA icon
89
DELISTED
Akoya BioSciences
AKYA
$1.28M 0.09%
+91,568
New +$1.53M
2021 Q3
0 quarters
RGEN icon
90
Repligen
RGEN
$11.1B
$1.27M 0.09%
4,402
+710
+19% +$182K
2021 Q1
2 quarters
ASMB icon
91
Assembly Biosciences
ASMB
$409M
$1.22M 0.08%
+29,167
New +$1.22M
2021 Q3
0 quarters
HSKA
92
DELISTED
Heska Corp
HSKA
$1.17M 0.08%
4,525
+1,113
+33% +$284K
2019 Q1
10 quarters
AMN icon
93
AMN Healthcare
AMN
$1.57B
$1.15M 0.08%
10,000
-149,101
-94% -$15.8M
2021 Q2
1 quarter
KRSA
94
Korsana Biosciences, Inc. Common Stock
KRSA
$1.47B
$1.14M 0.08%
+2,657
New +$1.22M
2021 Q3
0 quarters
PHAS
95
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$933K 0.06%
+300,000
New +$1M
2021 Q3
0 quarters
ENSG icon
96
The Ensign Group
ENSG
$10.3B
$779K 0.05%
10,397
+1,424
+16% +$118K
2017 Q4
15 quarters
ELDN icon
97
Eledon Pharmaceuticals
ELDN
$173M
$705K 0.05%
+114,008
New +$797K
2021 Q3
0 quarters
MIST icon
98
Milestone Pharmaceuticals
MIST
$88.1M
$649K 0.04%
+113,597
New +$640K
2021 Q3
0 quarters
DCPH icon
99
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$635K 0.04%
+18,700
New +$597K
2021 Q3
0 quarters
KRRO icon
100
PUT
Korro Bio
KRRO
$125M
$479K 0.03%
1,358
-492
-27% -$194K
2021 Q1
2 quarters
2 3
4
5 6

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Eversept Partners held 129 positions worth $1.45B, down 3.6% from $1.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Eversept Partners deployed $154M of net new capital in Q3 2021, opening 42 new positions and adding to 32 existing holdings. Its largest new stake was Labcorp: 149,354 shares worth $36.1M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 65% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Qiagen, an estimated $26.7M trimmed.

  • Eversept Partners's largest Q3 2021 buy was Labcorp: 149,354 shares worth $36.1M.
  • Eversept Partners added most to Community Health Systems in Q3 2021, an estimated $28.3M increase.
  • Eversept Partners's biggest Q3 2021 reduction was Qiagen, cutting an estimated $26.7M.
  • Eversept Partners fully exited Organon & Co in Q3 2021, selling an estimated $21.2M.
  • Eversept Partners's ten largest holdings make up 43% of its $1.45B portfolio in Q3 2021.
  • Eversept Partners opened 42 new positions and closed 24 in Q3 2021.
  • Eversept Partners's portfolio value fell 3.6% quarter-over-quarter to $1.45B.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.